Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
699 EUR | +1,52% | +0,50% | +30,42% |
02/05 | Novo Nordisk, Eli Lilly's medicijnen tegen gewichtsverlies krijgen prijsverlagingen in Groot-Brittannië | MT |
02/05 | Novo Nordisk: Wegovy, Ozempic prijzen in VS gedaald in Q1 | RE |
Omzet 2024 * | 42,76 mld. 39,83 mld. | Omzet 2025 * | 52,13 mld. 48,56 mld. | Marktkapitalisatie | 681 mld. 634 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 11,94 mld. 11,12 mld. | Nettowinst (verlies) 2025 * | 16,29 mld. 15,17 mld. | EV/omzet 2024 * | 16,4 x |
Nettoschuld 2024 * | 19,98 mld. 18,61 mld. | Nettoschuld 2025 * | 15,29 mld. 14,24 mld. | EV/omzet 2025 * | 13,3 x |
K/w-verhouding 2024 * |
56,3
x | K/w-verhouding 2025 * |
41,2
x | Werknemers | 43.000 |
Dividendrendement 2024 * |
0,69% | Dividendrendement 2025 * |
0,79% | Vrij verhandelbaar | 99,8% |
Recentste transcriptie over Eli Lilly and Company
1 dag | +1,52% | ||
1 week | +0,50% | ||
Lopende maand | -5,48% | ||
1 maand | -5,48% | ||
3 maanden | +15,63% | ||
6 maanden | +29,44% | ||
Lopend jaar | +30,42% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 56 | 01-01-96 |
Anat Ashkenazi
DFI | Director of Finance/CFO | 51 | 01-01-01 |
Ruth Gimeno
PSD | President | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 25-01-21 | |
Ralph Alvarez
BRD | Director/Board Member | 68 | 01-04-09 |
Jon Fyrwald
BRD | Director/Board Member | 63 | 01-01-05 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 688,6 | +2,08% | 15 |
02-05-24 | 712,9 | -1,55% | 0 |
30-04-24 | 724,1 | +6,06% | 0 |
29-04-24 | 682,7 | -0,86% | 0 |
26-04-24 | 688,6 | +2,08% | 15 |
slotkoers Wiener Boerse, 26 april 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,07% | 556 mld. | |
-4,35% | 361 mld. | |
+17,65% | 325 mld. | |
+3,77% | 285 mld. | |
+14,68% | 235 mld. | |
+4,71% | 199 mld. | |
-12,43% | 189 mld. | |
-3,79% | 157 mld. | |
-3,34% | 149 mld. |